CAS:1217471-51-6|N-[[5-[[(2R)-2-Amino-3-mercaptopropyl]amino][1,1′-biphenyl]-2-yl]carbonyl]-L-methionine Trifluoroacetate Salt

CAS:1217471-51-6|N-[[5-[[(2R)-2-Amino-3-mercaptopropyl]amino][1,1′-biphenyl]-2-yl]carbonyl]-L-methionine Trifluoroacetate Salt

Catalogue Number:A611953
Chemical Name:N-[[5-[[(2R)-2-Amino-3-mercaptopropyl]amino][1,1′-biphenyl]-2-yl]carbonyl]-L-methionine Trifluoroacetate Salt
Synonyms:(2S)-2-[[(5-[[(2R)-2-Amino-3-sulfanylpropyl]amino][1,1′-biphenyl]-2-yl)carbonyl]amino]-4-(methylsulfanyl)butanoic Acid Trifluoroacetate; FTI-276 Trifluoroacetate; (5-(((R)-2-Amino-3-mercaptopropyl)amino)-[1,1′-biphenyl]-2-carbonyl)-L-methionine Trifluoroacetate
CAS Number:1217471-51-6
Alternate CAS #
170006-72-1
Molecular Formula:C₂₁H₂₇N₃O₃S₂ • C ₂HF₃O₂
Molecular Weight:433.59 + 114.02
Category:Standards; Miscellaneous; Molecular Biology; Pharmaceutical/API Drug Impurities/Metabolites;
Applications:N-[[5-[[(2R)-2-Amino-3-mercaptopropyl]amino][1,1′-biphenyl]-2-yl]carbonyl]-L-methionine Trifluoroacetate Salt is a salt analog of N-[[5-[[(2R)-2-Amino-3-mercaptopropyl]amino][1,1′-biphenyl]-2-yl]carbonyl]-L-methionine (CAS# 170006-72-1), which is a farnesyltransferase inhibitor useful in attenuating nicotine and opioid withdrawal.
References:Moise, I., et al.: Bioorg. Med. Chem. Lett., 26, 3730 (2016); Singh, T. G., et al.: Behav. Pharmacol., 24, 668 (2013); Rehni, A. K., et al.: Neuropharmacology, 71, 19 (2013)
To ensure the stability of our products, the efficient express delivery service will be used. We also guarantee that the products will be shipped in the box with layers of tapes to protect them against damage. The extremely low temperature products will be wrapped with dried ice, and the low temperature products will be delivered with ice bags. As for the products stored at room temperature, they will not be packed with ice bags or dried ice. Taskcm is committed to providing cost-effective products that facilitate drug delivery with our customers.
Email:sales@ebclink.com

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *